Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,431
archived clinical trials in
Anemia

Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Status: Enrolling
Updated:  8/12/2015
University of North Carolina Hospitals and Clinics
mi
from
Chapel Hill, NC
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Short-Term Effects & Safety of an Accelerated Intravenous Iron Regimen in Patients With Heart Failure
Status: Enrolling
Updated: 8/12/2015
University of North Carolina Hospitals and Clinics
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease
Vitamin D Replacement in Chronic Kidney Disease and Its Effects on Iron Homeostasis, Serum Hepcidin, and Hemojuvelin Levels.
Status: Enrolling
Updated:  8/21/2015
University of Alabama
mi
from
Birmingham, AL
Effects of Vitamin D Replacement on Hormones Regulating Iron Metabolism in Individuals With Chronic Kidney Disease
Vitamin D Replacement in Chronic Kidney Disease and Its Effects on Iron Homeostasis, Serum Hepcidin, and Hemojuvelin Levels.
Status: Enrolling
Updated: 8/21/2015
University of Alabama
mi
from
Birmingham, AL
Click here to add this to my saved trials
Helen Keller International's Enhanced-Homestead Food Production Program in Burkina Faso
THE IMPACT OF THE ENHANCED HOMESTEAD FOOD PRODUCTION PROGRAM ON CHILD HEALTH
Status: Enrolling
Updated:  8/24/2015
International Food Policy Research Institute
mi
from
Washington,
Helen Keller International's Enhanced-Homestead Food Production Program in Burkina Faso
THE IMPACT OF THE ENHANCED HOMESTEAD FOOD PRODUCTION PROGRAM ON CHILD HEALTH
Status: Enrolling
Updated: 8/24/2015
International Food Policy Research Institute
mi
from
Washington,
Click here to add this to my saved trials
A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects
A Phase 1 Study to Investigate Absorption, Metabolism, and Excretion After Establishment of Steady State Via GBT440 Loading and Maintenance Dosing Followed by a Single Oral Dose Administration of [14C]-GBT440 in Healthy Male Subjects
Status: Enrolling
Updated:  9/3/2015
Covance Early Clinical Services
mi
from
Madison, WI
A Study of the Absorption, Metabolism, and Excretion of GBT440 in Healthy Male Subjects
A Phase 1 Study to Investigate Absorption, Metabolism, and Excretion After Establishment of Steady State Via GBT440 Loading and Maintenance Dosing Followed by a Single Oral Dose Administration of [14C]-GBT440 in Healthy Male Subjects
Status: Enrolling
Updated: 9/3/2015
Covance Early Clinical Services
mi
from
Madison, WI
Click here to add this to my saved trials
Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Gene Therapy for the Treatment of Fanconi's Anemia Type C
Retroviral Mediated Gene Transfer of the Fanconi Anemia Complementation Group C Gene to Hematopoietic Progenitors of Group C Patients
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Gene Therapy for the Treatment of Fanconi's Anemia Type C
Retroviral Mediated Gene Transfer of the Fanconi Anemia Complementation Group C Gene to Hematopoietic Progenitors of Group C Patients
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
Iron Replacement in Blood Donors
Iron Replacement in Blood Donors
Status: Enrolling
Updated:  9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Iron Replacement in Blood Donors
Iron Replacement in Blood Donors
Status: Enrolling
Updated: 9/26/2015
National Institutes of Health Clinical Center, 9000 Rockville Pike
mi
from
Bethesda, MD
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Birmingham, AL
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Maywood, IL
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Maywood, IL
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Louisville, KY
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Detroit, MI
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Brooklyn Center, MN
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Brooklyn Center, MN
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Las Vegas, NV
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Paterson, NJ
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Paterson, NJ
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Brooklyn, NY
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Mineola, NY
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
New York, NY
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Nashville, TN
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Morgantown, WV
A Study of Intravenous (iv) Mircera in Hemodialysis Patients With Chronic Renal Anemia
A Randomized, Open-label Study of Dose Conversion Factors for Maintenance Intravenous Mircera in Hemodialysis Patients With Chronic Renal Anemia
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
A Randomized, Open-Label, Multicenter Study Of Darbepoetin Alfa Administered Once Every Two Weeks (Q2W) Compared With rHuEPO Administered Once Every Week (QW) For The Treatment Of Anemia In Subjects With Non-Myeloid Malignancies Receiving Multiple Chemotherapy
Status: Enrolling
Updated:  10/1/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
A Randomized, Open-Label, Multicenter Study Of Darbepoetin Alfa Administered Once Every Two Weeks (Q2W) Compared With rHuEPO Administered Once Every Week (QW) For The Treatment Of Anemia In Subjects With Non-Myeloid Malignancies Receiving Multiple Chemotherapy
Status: Enrolling
Updated: 10/1/2015
Jonsson Comprehensive Cancer Center at UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Hot Springs, AR
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Hot Springs, AR
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Los Angeles, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Riverside, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Riverside, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Sacramento, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
San Jose, CA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
San Jose, CA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Boston, MA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Springfield, MA
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Springfield, MA
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Detroit, MI
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Brooklyn Center, MN
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Brooklyn Center, MN
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Raleigh, NC
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Toledo, OH
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Portland, OR
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Dallas, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Houston, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
San Antonio, TX
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
Clinical Research Facility
mi
from
Morgantown, WV
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated:  10/1/2015
mi
from
Bruxelles,
A Study of Subcutaneous Mircera for the Treatment of Anemia in Dialysis Patients.
A Randomized, Open-label Study of the Effect of Maintenance Subcutaneous Mircera on Hemoglobin Levels in Dialysis Patients With Chronic Kidney Disease
Status: Enrolling
Updated: 10/1/2015
mi
from
Bruxelles,
Click here to add this to my saved trials
Milking the Umbilical Cord at Term Cesarean Birth
Milking the Umbilical Cord at Term Cesarean Birth: Effect on Hemoglobin Levels in the First 48 Hours of Life
Status: Enrolling
Updated:  10/1/2015
Women and Infants Hospital
mi
from
Providence, RI
Milking the Umbilical Cord at Term Cesarean Birth
Milking the Umbilical Cord at Term Cesarean Birth: Effect on Hemoglobin Levels in the First 48 Hours of Life
Status: Enrolling
Updated: 10/1/2015
Women and Infants Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Status: Enrolling
Updated:  10/5/2015
University of Chicago
mi
from
Chicago, IL
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
T-Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Hematologic Malignancies
Status: Enrolling
Updated: 10/5/2015
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Colorado Cancer Research Program, Incorporated
mi
from
Denver, CO
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
Veterans Affairs Medical Center - Lakeside Chicago
mi
from
Chicago, IL
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
Veterans Affairs Medical Center - Lakeside Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
Robert H. Lurie Comprehensive Cancer Center at Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Illinois Oncology Research Association
mi
from
Peoria, IL
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Carle Cancer Center
mi
from
Urbana, IL
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Cedar Rapids Oncology Project
mi
from
Cedar Rapids, IA
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
CCOP - Iowa Oncology Research Association
mi
from
Des Moines, IA
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
MBCCOP - LSU Health Sciences Center
mi
from
New Orleans, LA
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
MBCCOP - LSU Health Sciences Center
mi
from
New Orleans, LA
Click here to add this to my saved trials
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated:  10/6/2015
Tufts - New England Medical Center
mi
from
Boston, MA
Erythropoietin (EPO)+/- Filgrastim (G-CSF) vs. Supportive Therapy Alone for Patients With Myelodysplastic Syndromes
Phase III Evaluation of EPO With or Without G-CSF Versus Supportive Therapy Alone in the Treatment of Myelodysplastic Syndromes
Status: Enrolling
Updated: 10/6/2015
Tufts - New England Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials